150 related articles for article (PubMed ID: 33638758)
41. Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship.
Gorini F; Sabatino L; Coi A; Iervasi G; Vassalle C
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682497
[TBL] [Abstract][Full Text] [Related]
42. Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.
Qu N; Hui Z; Shen Z; Kan C; Hou N; Sun X; Han F
Front Endocrinol (Lausanne); 2022; 13():873027. PubMed ID: 35600591
[TBL] [Abstract][Full Text] [Related]
43. A Unique Triad of Invasive Sinusitis, Brain Abscess with Focal Cerebritis, and COVID-19.
Shahab A; Arora A; Chhina SS; Dhillon S; Nazir U
Am J Case Rep; 2021 Oct; 22():e933177. PubMed ID: 34702794
[TBL] [Abstract][Full Text] [Related]
44. A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors.
Lui DTW; Tsoi KH; Lee CH; Cheung CYY; Fong CHY; Lee ACH; Tam AR; Pang P; Ho TY; Law CY; Lam CW; To KKW; Chow WS; Woo YC; Hung IFN; Tan KCB; Lam KSL
Endocrine; 2023 May; 80(2):380-391. PubMed ID: 36596904
[TBL] [Abstract][Full Text] [Related]
45. Acute oesophageal necrosis in a patient with recent SARS-CoV-2.
Mustafa NF; Jafri NS; Holtorf HL; Shah SK
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400428
[TBL] [Abstract][Full Text] [Related]
46. Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution.
Deligiorgi MV; Siasos G; Vakkas L; Trafalis DT
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830939
[TBL] [Abstract][Full Text] [Related]
47. Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer.
Basté Rotllan N
Cancer Med; 2022 Oct; 11 Suppl 1(Suppl 1):10-16. PubMed ID: 36202608
[TBL] [Abstract][Full Text] [Related]
48. Mild and asymptomatic SARS-CoV-2 infection is not associated with progression of thyroid dysfunction or thyroid autoimmunity.
Goyal A; Gupta Y; Kalaivani M; Tandon N
Clin Endocrinol (Oxf); 2023 Feb; 98(2):277-279. PubMed ID: 35384011
[No Abstract] [Full Text] [Related]
49. Post-COVID-19 Condition: Where Are We Now?
Boaventura P; Macedo S; Ribeiro F; Jaconiano S; Soares P
Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35455008
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection.
Parambil BC; Moulik NR; Dhamne C; Dhariwal N; Narula G; Vora T; Prasad M; Chichra A; Jatia S; Chinnaswamy G; Banavali S
Indian J Pediatr; 2022 May; 89(5):445-451. PubMed ID: 34378149
[TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists.
Giovanella L; Ruggeri RM; Petranović Ovčariček P; Campenni A; Treglia G; Deandreis D
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1719-1723. PubMed ID: 33765218
[No Abstract] [Full Text] [Related]
52. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer.
Fugazzola L; Elisei R; Fuhrer D; Jarzab B; Leboulleux S; Newbold K; Smit J
Eur Thyroid J; 2019 Oct; 8(5):227-245. PubMed ID: 31768334
[TBL] [Abstract][Full Text] [Related]
53. [Clinical Guidelines for Cancer Chemotherapy under COVID-19 in the World].
Katsumata N
Gan To Kagaku Ryoho; 2021 Aug; 48(8):992-995. PubMed ID: 34404063
[TBL] [Abstract][Full Text] [Related]
54. COVID-19 and Inherited Metabolic Disorders: One-Year Experience of a Referral Center.
Tummolo A; Paterno G; Dicintio A; Stefanizzi P; Melpignano L; Aricò M
Children (Basel); 2021 Sep; 8(9):. PubMed ID: 34572213
[TBL] [Abstract][Full Text] [Related]
55. The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations.
Grani G; Ciotti L; Del Gatto V; Montesano T; Biffoni M; Giacomelli L; Sponziello M; Pecce V; Verrienti A; Filetti S; Durante C
Endocrine; 2023 Jan; 79(1):45-48. PubMed ID: 35857273
[No Abstract] [Full Text] [Related]
56. The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients.
Deng J; Cai X; Chen Z
Exp Hematol Oncol; 2022 Sep; 11(1):52. PubMed ID: 36071512
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of cycle threshold values at deisolation.
Mowrer CT; Creager H; Cawcutt K; Birge J; Lyden E; Van Schooneveld TC; Rupp ME; Hewlett A
Infect Control Hosp Epidemiol; 2022 Jun; 43(6):794-796. PubMed ID: 33820588
[TBL] [Abstract][Full Text] [Related]
58. The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19.
Abobaker A; Darrat M
J Med Virol; 2021 Dec; 93(12):6449-6450. PubMed ID: 34260761
[No Abstract] [Full Text] [Related]
59. Lack of SARS-CoV-2 among Grand Magal de Touba pilgrims consulting for respiratory symptoms in October 2020.
Goumballa N; Dieng M; Sokhna C; Gautret P
Travel Med Infect Dis; 2021; 39():101916. PubMed ID: 33189885
[No Abstract] [Full Text] [Related]
60. The impact of COVID policies on the vitreoretinal service in St Paul's Eye Unit, Liverpool.
Dervenis N; Heimann H; Hussain RN; Chua PY; Sandinha T; Vilà N; Pearce I; Groenewald C; Tan SZ
Eye (Lond); 2021 Jun; 35(6):1783-1784. PubMed ID: 32709956
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
